Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Medulloblastoma Associated with Down Syndrome: From a Rare Event Leading to a Pathogenic Hypothesis. | Diagnostics (Basel) | 2021 | 33562188 | PubTator, text mining | PubMed |
| Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups. | J Egypt Natl Canc Inst | 2021 | 33555447 | PubTator, text mining | PubMed |
| Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance. | Adv Sci (Weinh) | 2021 | 33552868 | PubTator, text mining | PubMed |
| MicroRNA-200a and microRNA-141 have a synergetic effect on the suppression of epithelial-mesenchymal transition in liver cancer by targeting STAT4. | Oncol Lett | 2021 | 33552256 | PubTator, text mining | PubMed |
| Functional Analysis of Immune Signature Genes in Th1* Memory Cells Links ISOC1 and Pyrimidine Metabolism to IFN-γ and IL-17 Production. | J Immunol | 2021 | 33547171 | PubTator, text mining | PubMed |
| MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2021 | 33546241 | PubTator, text mining | PubMed |
| Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer. | Cells | 2021 | 33535617 | PubTator, text mining | PubMed |
| The exosome of platelet endothelial cell adhesion molecule-1 (PECAM1) protein: A potential risking star in high blood pressure patients (HBPP). | Medicine (Baltimore) | 2021 | 33530152 | PubTator, text mining | PubMed |
| High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human Tumors. | Cancer Res | 2021 | 33509940 | PubTator, text mining | PubMed |
| Personalized logical models to investigate cancer response to BRAF treatments in melanomas and colorectal cancers. | PLoS Comput Biol | 2021 | 33507915 | PubTator, text mining | PubMed |
| High-Content Analysis-Based Sensitivity Prediction and Novel Therapeutics Screening for c-Met-Addicted Glioblastoma. | Cancers (Basel) | 2021 | 33498427 | PubTator, text mining | PubMed |
| Medulloblastoma in adults - reviewing the literature from a surgeon's point of view. | Aging (Albany NY) | 2021 | 33497354 | PubTator, text mining | PubMed |
| Potential Physiological Relevance of ERAD to the Biosynthesis of GPI-Anchored Proteins in Yeast. | Int J Mol Sci | 2021 | 33494405 | PubTator, text mining | PubMed |
| Metabolic Effects of Recurrent Genetic Aberrations in Multiple Myeloma. | Cancers (Basel) | 2021 | 33494394 | PubTator, text mining | PubMed |
| The transcriptome-wide association search for genes and genetic variants which associate with BMI and gestational weight gain in women with type 1 diabetes. | Mol Med | 2021 | 33472578 | PubTator, text mining | PubMed |
| The Metabolic Role of GRK2 in Insulin Resistance and Associated Conditions. | Cells | 2021 | 33467677 | PubTator, text mining | PubMed |
| Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers. | Biomedicines | 2021 | 33466394 | PubTator, text mining | PubMed |
| Updated Insights on EGFR Signaling Pathways in Glioma. | Int J Mol Sci | 2021 | 33435537 | PubTator, text mining | PubMed |
| Advanced Techniques and Awaited Clinical Applications for Human Pluripotent Stem Cell Differentiation into Hepatocytes. | Hepatology | 2021 | 33420753 | PubTator, text mining | PubMed |
| Spatiotemporal profiling of cytosolic signaling complexes in living cells by selective proximity proteomics. | Nat Commun | 2021 | 33397984 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=36